These findings indicate a potential role of the IL20RA-PD-L1 axis in shaping the immune microenvironment of breast cancer by reducing the enrichment of anti-cancer CD8+ T lymphocytes and NK cells and decreasing the production of cytokines by TILs. Here, IL20RA is linked to cancer.